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ABSTRACT
Background: COVID-19 related illnesses have been associated with an increased prevalence of cardiovascular disease sequelae
and worsened socioeconomic variables. We sought to investigate the relationship between COVID-19 outcomes, underlying
cardiovascular disease, and socioeconomic determinants of health in rural and non-rural counties in the state of Georgia.
Methods: COVID-19, demographic, and socioeconomic data were acquired from publicly available databases including the
Centers for Disease Control and Prevention’s Social Vulnerability Index. The relationship between COVID-19 outcomes and
markers of cardiovascular disease burden, rurality, and socioeconomic determinants of health was assessed at the county level in
Georgia through the beginning of August 2020 using univariable and multivariable Poisson regression modeling.
Results: In adjusted models, the risk of COVID-19 incidence was significantly higher in residents of non-rural Georgia counties
while we observed no significant difference in COVID-19 case-fatality rates between residents of rural and non-rural Georgia
counties. A significant adverse association between risk of COVID-19 cumulative case-fatality rates and recent mortality rates of
stroke was detected, while counties with historically higher coronary heart disease death rates demonstrated significantly lower
risk ratio of COVID-19 cumulative case-fatality rates. Additionally, Georgia counties with worsened indices of social and
economic vulnerability demonstrated significantly higher risk ratio of COVID-19 incidence and case-fatality rates.
Conclusions: In Georgia, COVID-19 incidence is adversely associated with non-rural county status, while both incidence and
case-fatality rates are associated with historical indices of cardiovascular disease outcomes and higher social vulnerability. Efforts
to mitigate COVID-19 spread and improve COVID-19 outcomes in Georgia may require additional focus on these most
vulnerable areas.
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INTRODUCTION
A significant proportion of patients affected by COVID-19
have pre-existing cardiovascular comorbidities (Guzik et al.,
2020; Zheng et al., 2020). These patients have been found to
exhibit a higher risk of progression to more severe
COVID-19 infection (Paramasivam et al., 2020; Wang et al.,
2020; Zheng et al., 2020). COVID-19’s pro-inflammatory
effects on the cardiovascular system have been shown to be
mediated by its interaction with endothelial cell ACE2
receptors leading to potential widespread vascular damage,
myocardial injury, and cardiac arrhythmias (Bansal, 2020;
Huertas, 2020; Madjid et al., 2020; Varga et al., 2020). In
addition to populations with cardiovascular comorbidities,
rural communities face an increased risk of a higher
case-fatality ratio from COVID-19 compared to non-rural
communities (Kaufman et al; Lakhani et al., 2020). This risk
may be due to rural areas’ aging demographics, lower
socioeconomic resources, reduced access to care, and higher
rates of underlying chronic health conditions such as
cardiovascular disease (CVD) when compared to their
non-rural counterparts (Henning-Smith et al, 2020;
Kaufman et al, 2020; Peters, 2020; Souch and Cossman,
2020). Socially vulnerable populations are another group
disproportionately affected by COVID-19 due to structural
inequities in housing, nutrition, income, education, and
environment (Holuka et al., 2020; Karaye and Horney,
2020).
Due to the recent onset of the COVID-19 pandemic,
relationships between cardiovascular disease, rurality, social
vulnerability, and COVID-19 disease severity are still
emerging. We sought to better describe the relationship
between our dependent variables of COVID-19 incidence
and case-fatality rates with exposures such as
socioeconomic indices of health, rurality, and chronic CVD
burden across Georgia’s counties through the beginning of
August 2020. This was achieved by utilizing Georgia
Department of Public Health and CDC databases to
accumulate county-level data for the aforementioned
variables. Socioeconomic indices of health included factors
such as socioeconomic status, household composition,
minority status, and housing/transportation. County rurality
status was defined by the Georgia Department of Public
Health OASIS database, and the chronic CVD burden was
assessed by obtaining fatality rates of coronary heart
disease, heart failure, hypertension, stroke, and cardiac
dysrhythmias per 100,000.
METHODS
In this ecological study, county-level COVID-19 incidence
and mortality rates were retrospectively obtained from the
Georgia Department of Public Health Daily Status Report
from the beginning of the pandemic through August 1, 2020
(Georgia Department of Public Health, 2020). Rurality
status was obtained via the Georgia Department of Public
Health OASIS database (Georgia Department of Public
Health, 2020). 2016-2018 cardiovascular outcomes data for
all 159 Georgia counties was obtained from the CDC
database and included all forms of cardiovascular causes of
death expressed as number per 100,000 (Centers for Disease
Control and Prevention, 2020).
The US Centers for Disease Control and Prevention’s
(CDC) Social Vulnerability Index (SVI) is a measure of a
community’s susceptibility to adverse health impacts during
times of emergency such as disease outbreak (Centers for
Disease Control and Prevention, 2018) and this index was
used to help quantify socioeconomic variables across all
Georgia counties. The SVI is composed of four themes:
socioeconomic status, household composition, minority
status, and housing/transportation. This comprehensive
assessment tool allows for more granular assessment of a
community’s potential vulnerability in a public health crisis.
2018 CDC SVI data were used as a measure of social
vulnerability (Centers for Disease Control and Prevention,
2018). Each Georgia county was ranked for each of the four
main themes, ranging from 0 to 100, with 0 being the least
vulnerable county in the state and 100 being the most
vulnerable county in the state. In addition to the SVI, other
indices of economic well-being have been described. The
Distressed Community Index (DCI), a novel index focusing
upon economic metrics, represents another tool useful in
quantifying disparities between rural and non-rural
communities across the US (Khatana et al., 2019). This
composite index is composed of the following variables: no
high school diploma, poverty rate, adults not working,
housing vacancy rate, median household income, change in
employment, and change in establishments (Economic
Innovation Group, 2018). The most recent available
county-level DCI data (encompassing 2012-2016) expressed
as a nationally indexed ranked score ranging from 0 (best
performing county) to 100 (worst performing) was included
in an effort to better describe county-level economic health.
All of these variables were assembled into a county-level
database in which multivariable analysis was conducted as
soon as the COVID-19 data was input on August 1, 2020.
Statistical Methods
All statistical analysis was performed using SAS 9.4 and
statistical significance was assessed using an alpha level of
0.05. Descriptive statistics on all variables were determined
and included frequencies and percentages for categorical
variables and means and standard deviations for continuous
variables. Generalized linear regression models assuming a
Poisson distribution and log link and accounting for
overdispersion by deviance scaling were used to examine
the association of county level demographic, DCI, SVI
theme, cardiovascular death rates, and diabetes percentages
with COVID-19 cumulative incidence and cumulative
case-fatality rates. All continuous variables were centered to
their mean and the centered variables were used in
modeling. Georgia-based SVI rankings for SES, household,
minority, and housing and transportation themes were
categorized into quartiles. All variables were examined for
potential multicollinearity before modeling using variance
inflation factors. All variance inflation factors were less than
5 indicating no multicollinearity between variables. Simple
bivariate models were first examined for each individual
independent variable. Then a full multivariable model was
created and a backward model building strategy was used to
arrive at a final multivariable model for each outcome.
Non-significant variables were removed from each model
one at a time and model fit criteria including the scaled
Pearson chi-square, Akaike’s Information Criterion, and
Bayes Information Criterion. If all three fit statistics
decreased the variable remained out of the model, otherwise
the variable was placed back into the model and the next
non-significant variable was removed. For each outcome,
the final model consisted of main effects or interaction
terms that were statistically significant or needed in the
model to improve the model fit criteria. The estimated risk
ratio (RR) for COVID-19 cumulative incidence and
cumulative case fatality and corresponding 95% CI were
determined for each independent variable: non-rural vs
rural; each SVI quartile vs the lowest quartile; a 5% increase
for the distressed communities index, and percent with
diabetes; and a 100/100,000 increase in coronary heart
disease, heart failure, hypertension, stroke, and cardiac
dysrhythmia death rates.
RESULTS
COVID-19 Incidence – Poisson Regression Modeling
Results
In simple, bivariate models (Table 1), all variables except
cardiac dysrhythmia death rates were significantly
associated with COVID-19 incidence rates. Increased risk of
COVID-19 was seen in non-rural compared to rural
counties. Likewise, those with the highest and second
highest SES vulnerability, the highest and second highest
household vulnerability, the second lowest minority
vulnerability, and the highest and second lowest housing and
transportation vulnerability were at risk for incident
COVID-19. Risk of COVID-19 was higher in communities
with higher distress community indexes. Finally increasing
coronary heart disease, heart failure, hypertension, and
Table 1
Descriptive Statistics and Simple Poisson Regression Results on Georgia Counties
Variable n (%) or mean (SD) Cumulative Incidence Cumulative Case-Fatality
RR (95% CI) p-value RR (95% CI) p-value
COVID-19 Cumulative Incidence Rate/100,000 2416.6 (2464.6)
COVID-19 Cumulative Case Fatality Rate/100,000 2567.5 (2101.4)
Non-Rural† – n (%) 0.0477 <0.0001
Non-Rural 41 (25.8) 1.31 (1.01-1.72) 0.70 (0.59-0.83)
Rural 118 (74.2) 1.00
SVI SES Theme† – n (%) <0.0001 <0.0001
Highest Vulnerability 76-100 40 (25.2) 1.58 (1.05-2.38) 2.30 (1.87-2.84)
51-75 39 (24.5) 1.97 (1.40-2.58) 0.99 (0.82-1.21)
26-50 40 (25.2) 1.27 (0.95-1.72) 1.17 (0.95-1.43)
Lowest Vulnerability 0-25 40 (25.2) 1.00 1.00
SVI Household Theme† – n (%) <0.0001 0.0521
Highest Vulnerability 76-100 40 (25.2) 2.53 (1.84-3.48) 1.23 (0.96-1.58)
51-75 39 (24.5) 1.41 (1.07-1.85) 1.32 (1.07-1.62)
26-50 29 (24.5) 1.19 (0.89-1.60) 1.22 (0.97-1.53)
Lowest Vulnerability 0-25 41 (25.8) 1.00 1.00
SVI Minority Theme† – n (%) 0.0330 0.0283
Highest Vulnerability 76-100 39 (24.5) 1.30 (0.85-1.97) 0.81 (0.60-1.10)
51-75 40 (25.2) 1.41 (0.89-2.25) 1.10 (0.80-1.51)
26-50 40 (25.2) 1.87 (1.17-2.99) 0.88 (0.63-1.23)
Lowest Vulnerability 0-25 40 (25.2) 1.00 1.00
SVI Housing and Transportation Theme† – n (%) <0.0001 0.1868
Highest Vulnerability 76-100 40 (25.2) 2.32 (1.67-3.23) 1.29 (0.98-1.69)
51-75 39 (24.5) 1.29 (0.86-1.67) 1.25 (0.95-1.64)
26-50 40 (25.2) 1.44 (1.04-1.98) 1.10 (0.84-1.44)
Lowest Vulnerability 0-25 40 (25.2) 1.00 1.00
Distressed Communities Index‡ 66.9 (29.0) 1.04 (1.02-1.05) <0.0001 1.02 (1.01-1.04) <0.0001
Coronary Heart Disease Death Rate*§ 89.3 (29.2) 1.75 (1.23-2.48) 0.0017 1.05 (0.80-1.40) 0.7012
Heart Failure Death Rate*§ 106.7 (23.5) 1.85 (1.32-2.60) 0.0004 1.25 (0.95-1.64) 0.1125
Hypertension Death Rate*§ 143.4 (57.0) 1.37 (1.11-1.70) 0.0041 1.23 (1.06-1.43) 0.0061
Stroke Death Rate*§ 46.1 (6.2) 8.10 (1.43-45.86) 0.0181 11.69 (3.30-41.43) 0.0001
Cardiac Dysrhythmia Death Rate*§ 10.3 (10.0) 0.78 (0.10-5.78) 0.8054 2.27 (1.10-4.68) 0.0265
Percent with Diabetes‡ 12.9 (4.2) 1.20 (1.02-1.42) 0.0284 1.11 (0.98-1.26) 0.1091
Rate/100,000, †Estimated RR are for a 1-unit increase in the independent variable, ‡Estimated RR are for a 5% increase in the independent
variable, §Estimated RR are for a 100/100,000 increase in the independent variable. SVI = Social Vulnerability Index; SES = Socioeconomic
Status, RR = Risk Ratio.
stroke death rates and increasing diabetes prevalence were
associated with increased COVID-19 infection at the county
level.
The final multivariable model (Table 2) contained non-rural
status, each SVI theme, and heart failure death rates.
Counties that were non-rural, in the highest SES
vulnerability group, in the highest household vulnerability
group, in the second lowest minority vulnerability group, in
the highest housing and transportation vulnerability group,
and who had higher heart failure death rates had increased
risk of COVID-19 incidence.
COVID-19 Case-Fatality Rate - Multivariable Modeling
Results
In simple, bivariate models (Table 1), non-rural counties had
lower risk of cumulative case-fatality rates. Higher risk of
cumulative case-fatality rates was noted in the highest SES
vulnerability group and the second highest household
vulnerability group. Higher distress indexes and higher
hypertension, stroke, and cardiac dysrhythmia death rates
were also found to have an increased risk in simple,
bivariate models.
In the final multivariable model (Table 2), non-rurality was
not significantly associated with COVID-19 case-fatality
rates. Counties with the highest SES vulnerability, the
second highest and second lowest household vulnerability,
the second highest and second lowest housing and
transportation vulnerability, and counties with higher stroke
death rates were at increased risk of case-fatality. Counties
with the highest minority vulnerability and increasing
coronary heart disease death rates had lower risk of
case-fatality.
Table 2





Effect in Model Level RR (95%CI) p-value RR (95%CI) p-value
Non-Rural† Non-Rural vs Rural 1.98 (1.52-2.58) <0.0001
SVI SES Theme† Highest 76-100 vs Lowest Vulnerability 0-25 1.09 (0.64-1.88) 0.0200 1.54 (1.10-2.16) <0.0001
51-75 vs Lowest Vulnerability 0-25 1.24 (0.83-1.87) 0.73 (0.52-1.01)
26-50 vs Lowest Vulnerability 0-25 0.75 (0.51-1.11) 0.92 (0.69-1.24)
SVI Household Theme† Highest 76-100 vs Lowest Vulnerability 0-25 2.90 (1.97-4.28) <0.0001 1.24 (0.92-1.68) 0.0981
51-75 vs Lowest Vulnerability 0-25 1.10 (0.78-1.56) 1.32 (1.03-1.71)
26-50 vs Lowest Vulnerability 0-25 1.19 (0.91-1.56) 1.27 (1.02-1.59)
SVI Minority Theme† Highest 76-100 vs Lowest Vulnerability 0-25 0.95 (0.65-1.40) 0.0661 0.66 (0.49-0.89) 0.0161
51-75 vs Lowest Vulnerability 0-25 0.86 (0.58-1.29) 0.86 (0.64-1.16)
26-50 vs Lowest Vulnerability 0-25 1.29 (0.87-1.90) 0.80 (0.59-1.08)
SVI Housing and Transportation
Theme†
Highest 76-100 vs Lowest Vulnerability 0-25 2.04 (1.33-3.13) 0.0015 1.38 (0.99-1.93) 0.0413
51-75 vs Lowest Vulnerability 0-25 1.29 (0.91-1.84) 1.52 (1.14-2.03)
26-50 vs Lowest Vulnerability 0-25 1.51 (1.12-2.02) 1.31 (1.03-1.68)
Coronary Heart Disease Death
Rate§
0.65 (0.46-0.92) 0.0153
Heart Failure Death Rate§ 1.41 (0.95-2.08) 0.0877
Stroke Death Rate§ 8.46 (2.36-30.22) 0.0010
†Estimated RR are for a 1-unit increase in the independent variable, ‡Estimated RR are for a 5% increase in the independent variable, §Estimated
RR are for a 10/100,000 increase in the independent variable. SVI = Social Vulnerability Index; SES = Socioeconomic Status, RR = Risk Ratio.
DISCUSSION
Our multivariable regression modeling results indicate that
through the beginning of August 2020, non-rural counties in
Georgia exhibited significantly higher COVID-19 incidence
rates [RR=1.98; 95% CI (1.52, 2.58)]. This finding may be
the result of disparities in access to COVID-19 testing
across the state since the onset of the pandemic. As the
pandemic progresses nationwide, further investigation into
the relationship between rurality and COVID-19
epidemiology will likely remain a topic of significant
investigation.
Our analysis also revealed the association between higher
rates of coronary heart disease burden and lower COVID-19
case-fatality (Table 2). Using CDC-defined categories of
heart failure mortality rates at the county level reveals
higher COVID-19 incidence rates for counties with higher
rates of nearly all forms of recent, county-level heart failure
related mortality. COVID-19 case-fatality rates were most
strongly associated with counties demonstrating historically
higher rates of stroke [RR=8.46; 95% CI (2.36, 30.22)].
Holman et al (2020) recently reported worse outcomes in
both type 1 and 2 diabetic patients with a history of stroke
affected by COVID-19. The relationship between historical
stroke rates and worsened COVID-19 incidence and
outcomes may be related to the underlying relationship
between stroke and rurality. The CANHEART stroke study
published in 2019 revealed an adverse association between
rural status and stroke rates and fatality in Canada (Kapral et
al., 2019). In our multivariable model examining COVID-19
case-fatality, however, rural county status fell out of the
adjusted model while county level stroke mortality rates
remained (Table 2). This suggests that COVID-19 mortality
may be less influenced by geographic factors than
underlying disease burden characteristics across Georgia.
Due to the high burden of stroke across Georgia and the
southeastern United States, this finding warrants further
investigation in future studies.
As has been described in prior studies, poor socioeconomic
characteristics appear to be associated with worse
COVID-19 outcomes globally (Ahmed et al., 2020; de
Souza et al., 2020; Singu et al., 2020). Our data support
these international findings, but at the county level in
Georgia. The component themes of the SVI examine the
impact of differing socioeconomic factors upon a
community’s social vulnerability, particularly to infrequent
shocks to their economic and/or health stability. Our
multivariable analysis revealed similar results when
examining the impact of differing themes on COVID-19
incidence and case-fatality rates. Counties with the highest
socioeconomic vulnerability (SES theme) demonstrated
significantly higher risk of both COVID-19 incidence and
case-fatality. Mixed results were observed for other SVI
themes including household and minority themes (Table 2).
Intriguingly, counties with the highest minority vulnerability
index were found to have a significantly lower COVID-19
case-fatality rate. In contrast, Richmond and colleagues
reported the percentage of non-Hispanic white residents as
being the most protective variable in predicting COVID-19
case rates in their Georgia county-level analysis (Richmond
et al., 2020). These differing findings regarding the
epidemiology of COVID-19 and minority status across
Georgia could be accounted for by the different composite
variables that make up the Robert Woods Johnson
Foundation’s County Health Rankings utilized in
Richmond’s analysis, and the CDC’s SVI data used in this
study. Richmond et al did observe similar trends of low
socioeconomic status markers such as percent of children
living in poverty and percent of children qualifying for free
lunch being positively associated with COVID-19
cumulative case rates. Their results highlight differing study
designs between their analysis and ours, potentially owing
to the different sources and composition of the
socioeconomic data included in each analysis.
Another metric of county-level economic vulnerability, the
DCI, was associated with higher COVID-19 incidence and
case-fatality rates in univariate analysis. However, the DCI
failed to remain in the final adjusted model, perhaps owing
to DCI’s focus on variables more purely economic in nature.
It is important to note that the SVI’s socioeconomic,
household, and transportation themes did remain significant
in our adjusted findings, emphasizing that COVID-19
cumulative incidence and case fatality rates are observed to
be worse in more socially vulnerable counties in Georgia.
An unexpected but intriguing additional finding was that
counties with historically higher rates of cardiovascular
death attributable to coronary heart disease (CHD) were
associated with a decreased risk of COVID-19 cumulative
case fatality rates [RR=0.65 95% CI (0.46-0.92)]. A
hypothetical, yet untested, explanation for this protective
association between CHD mortality and COVID-19
mortality rates would be that of statin use. Statins, a class of
lipid lowering agents indicated for chronic administration in
patients with CHD, have been reportedly associated with
improved COVID-19 outcomes in several studies
(Castiglione et al., 2020; Kow and Hasan, 2020; Stone et al.,
2014; Zhang et al., 2020). Statin use has been shown to vary
geographically and across county lines. Counties with
greater racial and socioeconomic disparities, particularly
those with lower health insurance coverage and higher
proportions of Medicare Part D low-income subsidies were
associated with decreased statin use (Karpinski et al., 2019;
Schroff et al., 2017). While conjectural, further
investigation regarding the role of statin use for the
treatment and prevention of COVID-19 remains a topic of
investigation at an international scale.
Limitations
This study has several limitations. COVID-19 incidence
and case-fatality data have changed in Georgia since the
beginning of August 2020. Additionally, numerous other
socioeconomic and chronic health variables could be
included in this type of analysis. However, we sought to
utilize widely accepted indices of community vulnerability
and distress that are indexed nationally rather than create a
portfolio of independent variables ourselves. Additionally,
our background in cardiovascular medicine and clinical
observations of worse outcomes in patients with underlying
cardiovascular disease in Georgia led to our inclusion of
CDC data in this analysis.
While compiling population data from the county level
provided the opportunity for large-scale assessment, there is
the risk of aggregation bias and ecological fallacy when
extrapolating these results to the individual level. However,
county-level data was utilized in this analysis owing to the
availability of well accepted, nationally available
socioeconomic and clinical population-level data across
Georgia at the county level. Further exploratory work could
consider the role of other chronic diseases such as
pulmonary conditions or cancer and their impact on
COVID-19 outcomes.
CONCLUSIONS
Rural county status in the state of Georgia is associated with
a lower risk of COVID-19 incidence when compared to
non-rural counties through the beginning of August 2020.
Despite a lower observed incidence in rural counties, we
detected no significant difference in COVID-19 fatality
rates between rural and non-rural counties in adjusted
multivariable modeling. These findings may be related to
disparities not only in access to COVID-19 testing, but
clinical care as well. Worsened indices of socioeconomic
vulnerability and higher historical rates of stroke mortality
at the county-level are associated with poorer COVID-19
outcomes. Further investigation into the relationship
between preexisting cardiovascular disease burden,
particularly stroke, and COVID-19 outcomes appears
warranted.
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